GE

Genomictree Inc.

Develops molecular diagnostics using DNA methylation biomarkers for early cancer detection.

228760 | KO

Overview

Corporate Details

ISIN(s):
KR7228760005
LEI:
Country:
South Korea
Address:
대전광역시 유성구 테크노10로 44-6, 대전광역시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Genomictree Inc. is a biomarker-based molecular diagnostics company focused on developing and commercializing products for the early detection of cancer. The company specializes in identifying and utilizing DNA methylation biomarkers through its proprietary genomic-scale discovery tools. Its flagship product line, EarlyTect®, includes tests for the early screening of colorectal, lung, and bladder cancers. Genomictree also offers AccuraTect™ for companion diagnostics. The company's mission is to improve patient quality of life and reduce overall medical costs by providing innovative and accurate molecular diagnostic solutions to address unmet needs in the healthcare industry.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.6 MB
2025-06-18 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.7 KB
2025-06-18 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.7 KB
2025-06-18 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.5 KB
2025-06-18 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.5 KB
2025-06-16 00:00
Transaction in Own Shares
자기주식처분결과보고서
Korean 16.7 KB
2025-06-11 00:00
Transaction in Own Shares
주요사항보고서(자기주식처분결정)
Korean 29.1 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.3 MB
2025-03-26 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 17.9 KB
2025-03-18 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 556.0 KB
2025-03-14 00:00
Audit Report / Information
감사보고서제출
Korean 24.9 KB
2025-03-12 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집공고
Korean 148.6 KB
2025-03-11 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 6.9 KB
2025-03-11 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 145.7 KB
2025-03-11 00:00
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
Korean 149.7 KB

Automate Your Workflow. Get a real-time feed of all Genomictree Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Genomictree Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Genomictree Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Alteogen Inc. Logo
Biotech firm developing next-gen ADCs and biobetters with proprietary platform technologies.
South Korea
196170
ALTERITY THERAPEUTICS LTD Logo
Developing therapies for Parkinsonian disorders and MSA by inhibiting protein aggregation.
United States of America
ATHE
Alto Neuroscience, Inc. Logo
Developing precision medicines for depression and schizophrenia using a brain biomarker platform.
United States of America
ANRO
ALUMIS INC. Logo
Develops targeted oral therapies for immune-mediated diseases using precision immunology.
United States of America
ALMS
Alvotech Holdings S.A Logo
Develops and manufactures affordable biosimilar medicines for global patient access.
Luxembourg
ALVO
ALX ONCOLOGY HOLDINGS INC Logo
Clinical-stage firm developing CD47 inhibitors for hematologic and solid tumors.
United States of America
ALXO
Alzamend Neuro, Inc. Logo
Developing lithium & vaccine therapies for neurodegenerative & psychiatric disorders.
United States of America
ALZN
Alzinova AB Logo
Developing targeted immunotherapies, including a vaccine, for Alzheimer's disease.
Sweden
ALZ
AMARIN CORP PLC\UK Logo
Develops prescription therapies like Vascepa® to reduce cardiovascular risk for patients.
United States of America
AMRN
AMGEN INC Logo
Biotech pioneer developing innovative human therapeutics for the world's toughest diseases.
United States of America
AMGN

Talk to a Data Expert

Have a question? We'll get back to you promptly.